Natera, Inc. (NTRA)
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited genetic conditions. Anora, a miscarriage analysis product that examines fetal chromosomes to help understand the cause of pregnancy loss. Non-invasive paternity testing, which establishes paternity during gestation using blood samples from both the pregnant mother and the alleged father. Beyond reproductive health, Natera also provides specialized tests: Signatera, a sophisticated circulating tumor DNA (ctDNA) technology capable of screening for a generic set of mutations, independent of the individual's specific tumor characteristics. Prospera, a test used to assess and monitor organ transplant rejection. Additionally, the company offers Constellation, a cloud-based software platform that provides laboratory clients with access to Natera's proprietary algorithms and bioinformatics, enabling them to validate and launch their own tests. Natera distributes its products through a direct sales team and an extensive network of approximately 100 laboratory and distribution partners. The company has strategic partnerships, including one with BGI Genomics Co., Ltd. for the development, manufacturing, and commercialization of NGS-based genetic testing assays, and another with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. Founded in 2003, Natera, Inc. is headquartered in Austin, Texas. It was formerly known as Gene Security Network, Inc. before changing its name in 2012.
Sector: Services-Medical Laboratories
Industry: Medical - Diagnostics & Research
Natera, Inc.
NASDAQ:NTRAHealthcare · Medical - Diagnostics & Research
-4.98%$414.30
AH$414.30+0.00%vs close
Mkt Cap$59.72B
Float135.16M
O/S144.14M
Vol
$ Vol
RVOL
Inst Own94.8%
SI4.3%
Earnings
Dilution
Financials Summary
Revenue$2.31B
Net Income-$208.16M
Total Assets$2.51B
Free Cash Flow$109.11M
Debt & Equity
Debt 11%
Equity 89%
Total Debt$214.38M
Total Equity$1.71B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in NTRA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$2.51B
Liabilities$795.62M
Accounts Receivable$296.53M
Accounts Payable$33.16M
Inventory$68.44M
PP&E (Net)$349.73M
Goodwill$141.07M
Intangible Assets$373.71M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $2.31B | $1.7B | $1.08B | $820.22M | $625.49M | $391M | $302.33M | $257.65M | $210.94M | $217.07M | $190.35M | $159.29M | $55.17M | $14.25M |
| YoY Growth | 35.9% | 56.7% | 32.0% | 31.1% | 60.0% | 29.3% | 17.3% | 22.1% | -2.8% | 14.0% | 19.5% | 188.7% | 287.2% | - |
| Cost of Revenue | $810.63M | $673.75M | $589.83M | $456.26M | $318.42M | $203.62M | $175.47M | $166.06M | $139.6M | $135.57M | $112.84M | $78.4M | $37.27M | $11.15M |
| Gross Profit | $1.5B | $1.02B | $492.74M | $363.97M | $307.07M | $187.38M | $126.86M | $91.6M | $71.34M | $81.5M | $77.51M | $80.89M | $17.9M | $3.1M |
| Gross Margin | 64.8% | 60.3% | 45.5% | 44.4% | 49.1% | 47.9% | 42.0% | 35.6% | 33.8% | 37.5% | 40.7% | 50.8% | 32.4% | 21.7% |
| Research and Development | $624.11M | $404.14M | $320.68M | $316.42M | $264.21M | $100.03M | $51.36M | $51.35M | $50.06M | $41.86M | $27.71M | $17.29M | $11.55M | $6.98M |
| Selling, General, and Administrative | $1.18B | $841.31M | $618.31M | $588.59M | $511.03M | $303.63M | $206.18M | $154.87M | $155.31M | $136.13M | $109.64M | $62.94M | $31.61M | $15.33M |
| Other | $4.03M | $0 | $0 | $0 | $0 | $0 | -$14.39M | $0 | $0 | $0 | $0 | $0 | $98K | $0 |
| Total Operating Expenses | $1.81B | $1.25B | $938.99M | $905.01M | $775.24M | $403.66M | $243.15M | $206.23M | $205.37M | $177.99M | $137.35M | $80.23M | $43.16M | $22.31M |
| Operating Income (EBIT) | -$309.91M | -$222.29M | -$446.25M | -$541.04M | -$468.17M | -$216.28M | -$116.29M | -$114.63M | -$134.03M | -$96.49M | -$59.84M | $665K | -$25.27M | -$19.21M |
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.8% | -55.3% | -38.5% | -44.5% | -63.5% | -44.4% | -31.4% | 0.4% | -45.8% | -134.8% |
| Interest Expense | $4.07M | $10.69M | $12.64M | $9.32M | $8.3M | $15.08M | $10.69M | $10.48M | $4.21M | $533K | $3.5M | $4.22M | $11.94M | $0 |
| Interest Income | $45.89M | $43.25M | $24.35M | $3.54M | $5.38M | $7.56M | $4.15M | $0 | $2.38M | $1.4M | $964K | $118K | $0 | $56.96M |
| Other Income (Expense) | $41.82M | $32.56M | $11.71M | -$5.78M | -$2.92M | -$13.37M | -$6.54M | -$13.21M | -$1.83M | $865K | -$10.44M | -$5.82M | -$11.84M | -$56.96M |
| Income Before Tax (EBT) | -$268.09M | -$189.73M | -$434.53M | -$546.82M | -$471.1M | -$229.65M | -$122.83M | -$127.83M | -$135.86M | -$95.62M | -$70.28M | -$5.15M | -$37.11M | -$76.17M |
| Income Tax Expense | -$59.93M | $695K | $271K | $978K | $618K | $98K | $2M | $321K | $454K | $142K | $0 | $0 | $0 | $0 |
| Net Income | -$208.16M | -$190.43M | -$434.8M | -$547.8M | -$471.72M | -$229.74M | -$124.83M | -$128.15M | -$136.31M | -$95.77M | -$70.28M | -$5.15M | -$37.11M | -$76.17M |
| Net Income Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | -3.2% | -67.3% | -534.5% |
| Supplementary Data | ||||||||||||||
| EPS | -1.52 | -1.53 | -3.78 | -5.57 | -5.21 | -2.84 | -1.79 | -2.22 | -2.56 | -1.86 | -1.47 | -0.14 | -1.01 | -24.37 |
| Diluted EPS | -1.52 | -1.53 | -3.78 | -5.57 | -5.21 | -2.84 | -1.79 | -2.22 | -2.54 | -1.86 | -1.47 | -0.14 | -1.01 | -24.37 |
| Weighted Average OS | 136.72M | 124.72M | 115.00M | 98.41M | 90.56M | 81.01M | 69.56M | 57.73M | 53.31M | 51.45M | 47.65M | 36.69M | 36.69M | 3.13M |
| EBITDA | -$220.54M | -$148.08M | -$397.8M | -$520.8M | -$451.54M | -$205.95M | -$104.41M | -$107.13M | -$125.82M | -$93.37M | -$61.23M | $4.21M | -$22.74M | -$18.49M |
| EBITDA Margin | -9.6% | -8.7% | -36.7% | -63.5% | -72.2% | -52.7% | -34.5% | -41.6% | -59.6% | -43.0% | -32.2% | 2.6% | -41.2% | -129.8% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $1.08B | $945.59M | $642.1M | $466.09M | $84.39M | $48.67M | $61.93M | $46.41M | $12.62M | $15.26M | $28.95M | $87.18M | $30.5M | $5.76M |
| Short-Term Investments | $0 | $22.69M | $236.88M | $432.3M | $829.9M | $688.61M | $379.06M | $107.46M | $106.25M | $130.86M | $201.59M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1.08B | $968.28M | $878.98M | $898.39M | $914.28M | $737.27M | $440.99M | $153.87M | $118.87M | $146.12M | $230.53M | $87.18M | $30.5M | $5.76M |
| Accounts Receivable | $296.53M | $314.17M | $278.29M | $244.38M | $122.07M | $78.56M | $53.35M | $62.22M | $44.09M | $13.4M | $5.86M | $5.94M | $6.63M | $1.31M |
| Inventory | $68.44M | $44.74M | $40.76M | $35.41M | $26.91M | $20.03M | $12.39M | $13.63M | $9M | $6.41M | $8.09M | $11.54M | $10.65M | $1.6M |
| Other Current Assets | $55.83M | $48.63M | $60.52M | $33.63M | $228K | $187K | $55K | $4.6M | $59K | $1.09M | $901K | $503K | $150K | $340K |
| Total Current Assets | $1.5B | $1.38B | $1.26B | $1.21B | $1.09B | $862.66M | $523.17M | $240.52M | $180.63M | $174.12M | $250.73M | $106.48M | $49.11M | $9.01M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $349.73M | $248.19M | $167.75M | $164.33M | $124.53M | $54.75M | $47.01M | $24.34M | $29.67M | $32.29M | $12.71M | $14.57M | $9.79M | $4.07M |
| Goodwill | $141.07M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $373.71M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $207K |
| Deferred Tax Assets | $109.69M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $36.9M | $36.72M | $15.4M | $18.33M | $18.82M | $14.74M | $12.48M | $3.32M | $4.32M | $4.28M | $1.8M | $2.57M | $825K | -$1 |
| Total Long-Term Assets | $1.01B | $284.92M | $183.15M | $182.66M | $143.35M | $69.49M | $59.49M | $27.65M | $33.99M | $36.56M | $14.51M | $17.15M | $10.62M | $4.28M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 |
| Total Assets | $2.51B | $1.66B | $1.44B | $1.39B | $1.24B | $932.15M | $582.66M | $268.17M | $214.61M | $210.68M | $265.24M | $123.62M | $59.72M | $13.29M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $33.16M | $34.92M | $15M | $31.15M | $27.21M | $8.1M | $8.6M | $14.59M | $8.53M | $11.48M | $7.33M | $8.87M | $11.3M | $4.5M |
| Short-Term Debt | $80.32M | $80.36M | $80.4M | $80.35M | $50.05M | $50.05M | $50.12M | $50.15M | $50.11M | $49.62M | $42.09M | $2.34M | $1.84M | $131.75M |
| Current Income Tax Payable | $0 | $4.42M | $3.73M | $4.32M | $2.23M | $1.72M | $1.69M | $1.25M | $504K | $459K | $346K | $367K | $241K | $0 |
| Current Unearned Revenue | $24.91M | $19.75M | $16.61M | $10.78M | $7.4M | $50.13M | $56.02M | $4.13M | $1.42M | $574K | $144K | $112K | $970K | $314K |
| Other Current Liabilities | $102.11M | $73.39M | $69.1M | $62.96M | $58.15M | $47.74M | $25.5M | $22.68M | $19.04M | $22.39M | $12.24M | $8.31M | $3.71M | $952K |
| Total Current Liabilities | $441.23M | $344.05M | $307.27M | $310.5M | $218.96M | $199.05M | $179.87M | $113.98M | $105.56M | $96.42M | $80.47M | $29.87M | $23.57M | $138.9M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $282.94M | $281.65M | $280.39M | $202.49M | $73.66M | $73.36M | $73.06M | $0 | $0 | $24.47M | $22.46M | $0 |
| Long-Term Unearned Revenue | $17.06M | $16.84M | $19.13M | $20M | $21.32M | $22.8M | $23.81M | $40.06M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $110.39M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $108.47M | $7.84M | $0 | $0 | $1.48M | $320K | $310K | $8.61M | $10.57M | $7.79M | $0 | $240.61M | $185.2M | $0 |
| Total Long-Term Liabilities | $354.4M | $121.27M | $369.1M | $378.23M | $364.23M | $246.86M | $124.07M | $122.03M | $83.64M | $7.79M | $0 | $265.09M | $207.66M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $795.62M | $465.31M | $676.37M | $688.73M | $583.18M | $445.92M | $303.94M | $236.01M | $189.2M | $104.2M | $80.47M | $294.96M | $231.23M | $138.9M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10.52M |
| Common Stock | $14K | $12K | $11K | $11K | $10K | $9K | $8K | $7K | $6K | $5K | $5K | $1K | $1K | $1K |
| Retained Earnings | -$2.78B | -$2.57B | -$2.38B | -$1.94B | -$1.39B | -$929.32M | -$699.17M | -$574.53M | -$446.38M | -$345.85M | -$250.08M | -$179.81M | -$174.66M | -$137.55M |
| Comprehensive Income & Other | -$258K | -$344K | -$3.08M | -$16.36M | -$2.29M | $4.26M | $919K | -$552K | -$766K | -$725K | -$1.42M | $0 | $0 | $0 |
| Other Stockholders' Equity | $4.49B | $3.76B | $3.14B | $2.65B | $2.05B | $1.42B | $977.87M | $606.68M | $471.79M | $452.32M | $434.84M | $8.47M | $3.15M | $11.94M |
| Total Equity | $1.71B | $1.2B | $765.33M | $705.74M | $653.3M | $486.24M | $278.71M | $32.16M | $25.42M | $106.48M | $184.76M | -$171.34M | -$171.51M | -$125.61M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.51B | $1.66B | $1.44B | $1.39B | $1.24B | $932.15M | $582.66M | $268.17M | $214.61M | $210.68M | $265.24M | $123.62M | $59.72M | $13.29M |
| Supplementary Data | ||||||||||||||
| Total Debt | $214.38M | $187.12M | $441.99M | $446.22M | $397.23M | $281.09M | $155.81M | $123.51M | $123.18M | $49.62M | $42.09M | $26.81M | $24.31M | $131.75M |
| Net Debt | -$861.76M | -$758.47M | -$200.1M | -$19.87M | $312.85M | $232.43M | $93.89M | $77.1M | $110.56M | $34.37M | $13.14M | -$60.36M | -$6.19M | $125.99M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$208.16M | -$190.43M | -$434.8M | -$547.8M | -$471.72M | -$229.74M | -$124.83M | -$128.15M | -$137.63M | -$100.33M | -$70.28M | -$5.15M | -$37.11M | -$76.17M |
| Depreciation & Amortization | $43.48M | $30.97M | $24.1M | $16.7M | $11.25M | $8.61M | $7.73M | $7.5M | $7.14M | $6.18M | $5.54M | $5.15M | $2.53M | $723K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $354.4M | $274.43M | $191.81M | $152.38M | $115.22M | $50.17M | $28.62M | $14.2M | $11.4M | $10.6M | $7.33M | $5.16M | $1.66M | $605K |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $20.75M | -$35.88M | -$33.9M | -$122.31M | -$43.51M | -$25.83M | $2.42M | -$18.09M | $6.32M | -$3.96M | -$450K | $341K | -$5.85M | -$675K |
| Inventory | -$20.87M | -$3.98M | -$5.35M | -$8.5M | -$6.88M | -$7.47M | $917K | -$4.9M | -$3.09M | -$431K | $2.93M | -$890K | -$9.05M | -$891K |
| Accounts Payable | $753K | $13.21M | -$15.46M | $5.46M | $19.22M | -$118K | -$6.26M | $3.78M | $217K | $1.26M | $1.35M | -$2.43M | $6.79M | $0 |
| Other Working Capital | $9.41M | $28.79M | $6.76M | $42.2M | -$14.44M | -$5.71M | $30.13M | $46.37M | $16.16M | $5.47M | $5.52M | $6.41M | $6.35M | $0 |
| Total Working Capital Change | $10.04M | $2.14M | -$47.95M | -$83.15M | -$45.6M | -$39.13M | $27.2M | $27.16M | $19.61M | $2.34M | $9.35M | $3.43M | -$1.76M | -$1.57M |
| Other Non-Cash Items | $15.53M | $18.55M | $19.89M | $30.36M | $55.61M | $27.58M | -$2.17M | $8.72M | $1.65M | $7.16M | $10.23M | $1.91M | $10.56M | $60.54M |
| Net Cash from Operating | $215.3M | $135.66M | -$246.96M | -$431.5M | -$335.24M | -$182.51M | -$63.44M | -$70.58M | -$97.83M | -$74.05M | -$37.83M | $10.49M | -$24.13M | -$14.9M |
| Investing Activities | ||||||||||||||
| Capital Expenditures | -$139.19M | -$66.42M | -$39.2M | -$47.7M | -$41.03M | -$19.6M | -$4.97M | -$3.88M | -$9.87M | -$23.14M | -$7.85M | -$9.96M | -$8.24M | -$4.59M |
| Acquisitions | -$16.02M | $0 | $0 | $0 | $0 | $0 | $9.68M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | -$124.68M | -$98.3M | -$86.95M | -$876.1M | -$685.24M | -$446.63M | -$170.27M | -$272.82M | -$53.52M | -$203.29M | $0 | $0 | $0 |
| Sales of Investments | $23M | $339.22M | $306M | $464.98M | $720.49M | $373.38M | $175.57M | $168.99M | $296.47M | $123.69M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$10.49M | $0 | $0 | -$8.56M | $0 | $0 | $0 | $0 | $0 | $463K | $15K | $0 | $0 |
| Net Cash from Investing | -$132.21M | $137.62M | $168.5M | $330.34M | -$205.19M | -$331.46M | -$266.35M | -$5.16M | $13.78M | $47.03M | -$210.68M | -$9.94M | -$8.24M | -$4.59M |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | $82K | - | -$30M | - | -$199.56M | - | - | -$75M | -$7M | $33.16M | -$2.63M | -$25.23M | - |
| Common Stock Issuance | $47.46M | $30.29M | $254.46M | $452.64M | $576.19M | $301.29M | $340.77M | $113.72M | $5.66M | $6.18M | $181.26M | $53.92M | $33.26M | $65K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$27K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$287K | $0 | -$6K | -$415K | -$1.36M | $15K |
| Net Cash from Financing | $47.46M | $30.2M | $254.46M | $482.64M | $576.19M | $500.85M | $340.77M | $113.72M | $80.37M | $13.18M | $190.28M | $56.13M | $57.13M | $53K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $130.55M | $303.49M | $176M | $381.48M | $35.76M | -$13.13M | $10.98M | $37.98M | -$3.67M | -$13.84M | -$58.23M | $56.68M | $24.75M | -$19.44M |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | $215.3M | $135.66M | -$246.96M | -$431.5M | -$335.24M | -$182.51M | -$63.44M | -$70.58M | -$96.79M | -$73.9M | -$37.83M | $10.49M | -$24.13M | -$14.9M |
| Capital Expenditure | -$106.19M | -$66.42M | -$39.2M | -$47.7M | -$41.03M | -$19.6M | -$4.97M | -$3.88M | -$9.87M | -$23.14M | -$7.85M | -$9.96M | -$8.24M | -$4.59M |
| Free Cash Flow | $109.11M | $69.24M | -$286.15M | -$479.2M | -$376.27M | -$202.12M | -$68.41M | -$74.46M | -$106.66M | -$97.04M | -$45.68M | $533K | -$32.38M | -$19.49M |
| Cash at Beginning | $945.59M | $642.1M | $466.09M | $84.61M | $48.85M | $61.98M | $51M | $13.02M | $16.69M | $30.53M | $87.18M | $30.5M | $5.75M | $25.19M |
| Cash at End | $1.08B | $945.59M | $642.1M | $466.09M | $84.61M | $48.85M | $61.98M | $51M | $13.02M | $16.69M | $28.95M | $87.18M | $30.5M | $5.75M |